Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.73 USD | +0.39% |
|
+0.89% | +26.26% |
06-28 | Barclays Raises Catalent's Price Target to $63 From $47, Maintains Equalweight Rating | MT |
06-27 | Barclays Adjusts Catalent Price Target to $63 From $47 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.26% | 10.27B | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Transcript : Catalent, Inc. Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-08-2018 11